Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher R M Asquith

Showing results (21-30 of 57) with videos related to

Pageof 6
Sort By:
Bioorganic & Medicinal Chemistry Letters|July 8, 2020
Potent antiviral activity of novel multi-substituted 4-anilinoquin(az)olinesSirle Saul, Szu-Yuan Pu, William J Zuercher, et al.
Molecules (Basel, Switzerland)|April 11, 2020
New Insights into 4-Anilinoquinazolines as Inhibitors of Cardiac Troponin I-Interacting Kinase (TNNi3K)Christopher R M Asquith, Tuomo Laitinen, Carrow I Wells, et al.
Bioorganic & Medicinal Chemistry Letters|August 6, 2019
Anti-tubercular activity of novel 4-anilinoquinolines and 4-anilinoquinazolinesChristopher R M Asquith, Neil Fleck, Chad D Torrice, et al.
Antibiotics (Basel, Switzerland)|July 8, 2020
Antimicrobial and Antifungal Activity of Rare Substituted 1,2,3-Thiaselenazoles and Corresponding Matched Pair 1,2,3-DithiazolesTuomo Laitinen, Ilia V Baranovsky, Lidia S Konstantinova, et al.
Bioorganic & Medicinal Chemistry|August 1, 2022
Corrigendum to "Synthesis and evaluation of 1,2,3-dithiazole inhibitors of the nucleocapsid protein of feline immunodeficiency virus (FIV) as a model for HIV infection" [Bioorg. Med. Chem. 68 (2022) 116834]Tuomo Laitinen, Theres Meili, Maria Koyioni, et al.
Bioorganic & Medicinal Chemistry|June 2, 2022
Synthesis and evaluation of 1,2,3-dithiazole inhibitors of the nucleocapsid protein of feline immunodeficiency virus (FIV) as a model for HIV infectionTuomo Laitinen, Theres Meili, Maria Koyioni, et al.
Plos One|July 27, 2018
Identification of lead anti-human cytomegalovirus compounds targeting MAP4K4 via machine learning analysis of kinase inhibitor screening dataBlair L Strang, Christopher R M Asquith, Hanan F Moshrif, et al.
Chemmedchem|August 20, 2019
Targeting an EGFR Water Network with 4-Anilinoquin(az)oline Inhibitors for ChordomaChristopher R M Asquith, Kaitlyn A Maffuid, Tuomo Laitinen, et al.
Bioorganic & Medicinal Chemistry Letters|May 19, 2019
Synthesis and comparison of substituted 1,2,3-dithiazole and 1,2,3-thiaselenazole as inhibitors of the feline immunodeficiency virus (FIV) nucleocapsid protein as a model for HIV infectionChristopher R M Asquith, Theres Meili, Tuomo Laitinen, et al.
Chemmedchem|January 5, 2019
Investigation of the Pentathiepin Functionality as an Inhibitor of Feline Immunodeficiency Virus (FIV) via a Potential Zinc Ejection Mechanism, as a Model for HIV InfectionChristopher R M Asquith, Tuomo Laitinen, Lidia S Konstantinova, et al.
Pageof 6

Showing results (21-30 of 57) with videos related to

Sort By:
Pageof 6
Bioorganic & Medicinal Chemistry Letters|July 8, 2020
Potent antiviral activity of novel multi-substituted 4-anilinoquin(az)olinesSirle Saul, Szu-Yuan Pu, William J Zuercher, et al.
Molecules (Basel, Switzerland)|April 11, 2020
New Insights into 4-Anilinoquinazolines as Inhibitors of Cardiac Troponin I-Interacting Kinase (TNNi3K)Christopher R M Asquith, Tuomo Laitinen, Carrow I Wells, et al.
Bioorganic & Medicinal Chemistry Letters|August 6, 2019
Anti-tubercular activity of novel 4-anilinoquinolines and 4-anilinoquinazolinesChristopher R M Asquith, Neil Fleck, Chad D Torrice, et al.
Antibiotics (Basel, Switzerland)|July 8, 2020
Antimicrobial and Antifungal Activity of Rare Substituted 1,2,3-Thiaselenazoles and Corresponding Matched Pair 1,2,3-DithiazolesTuomo Laitinen, Ilia V Baranovsky, Lidia S Konstantinova, et al.
Bioorganic & Medicinal Chemistry|August 1, 2022
Corrigendum to "Synthesis and evaluation of 1,2,3-dithiazole inhibitors of the nucleocapsid protein of feline immunodeficiency virus (FIV) as a model for HIV infection" [Bioorg. Med. Chem. 68 (2022) 116834]Tuomo Laitinen, Theres Meili, Maria Koyioni, et al.
Bioorganic & Medicinal Chemistry|June 2, 2022
Synthesis and evaluation of 1,2,3-dithiazole inhibitors of the nucleocapsid protein of feline immunodeficiency virus (FIV) as a model for HIV infectionTuomo Laitinen, Theres Meili, Maria Koyioni, et al.
Plos One|July 27, 2018
Identification of lead anti-human cytomegalovirus compounds targeting MAP4K4 via machine learning analysis of kinase inhibitor screening dataBlair L Strang, Christopher R M Asquith, Hanan F Moshrif, et al.
Chemmedchem|August 20, 2019
Targeting an EGFR Water Network with 4-Anilinoquin(az)oline Inhibitors for ChordomaChristopher R M Asquith, Kaitlyn A Maffuid, Tuomo Laitinen, et al.
Bioorganic & Medicinal Chemistry Letters|May 19, 2019
Synthesis and comparison of substituted 1,2,3-dithiazole and 1,2,3-thiaselenazole as inhibitors of the feline immunodeficiency virus (FIV) nucleocapsid protein as a model for HIV infectionChristopher R M Asquith, Theres Meili, Tuomo Laitinen, et al.
Chemmedchem|January 5, 2019
Investigation of the Pentathiepin Functionality as an Inhibitor of Feline Immunodeficiency Virus (FIV) via a Potential Zinc Ejection Mechanism, as a Model for HIV InfectionChristopher R M Asquith, Tuomo Laitinen, Lidia S Konstantinova, et al.
Pageof 6